Clinical Trials Browser

UNKNOWN × Lymphoma, Extranodal NK-T-Cell × tislelizumab × Clear all

NCT05254899 2022-02-24

Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTL

Phase 2 Unknown

Lymphoma, Extranodal NK-T-Cell